扑热息痛中国行业研究报告

In the past ten years, Chinese paracetamol industry developed quickly, its output, export and domestic consumption all increased by over 10%. At the same time, PAP output in China grew quickly with a CAGR of 16.38%. What’s the production cost in China’s paracetamol and PAP producers? What constitute their production costs? What’s the profit margin to Chinese producers? In order to find the answers to these questions, CCM carries out this benchmarking analysis to China’s paracetamol and PAP production at present. After various paracetamol and PAP production methods are introduced briefly, the report dwells on the most popular methods for the benchmarking of paracetamol and PAP production cost and profit in China by finding answers to the following questions:  What raw materials are involved in China’s paracetamol and PAP production?  What is raw material cost?  What is the manufacturing cost?  What is the management cost?  What’s the production cost? And how does it differ from different manufacturers?  What’s the profit in Chinese manufacturers? This report provides two case analysis for the production cost and profit of paracetamol and two case analysis for the production cost and profit of PAP, respectively. With this report, the reader will have a clear picture of China's paracetamol and PAP production level and know where China is weak and where it is strong in paracetamol and PAP production. Also, future technology structure of PAP is also forecasted in the end of the report